These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6861880

  • 1. Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
    Müller-Schweinitzer E, Rosenthaler J.
    Eur J Pharmacol; 1983 Apr 22; 89(1-2):1-8. PubMed ID: 6861880
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.
    Müller-Schweinitzer E.
    Cardiovasc Drugs Ther; 1990 Dec 22; 4(6):1455-60. PubMed ID: 2127899
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological actions of the main metabolites of dihydroergotamine.
    Müller-Schweinitzer E.
    Eur J Clin Pharmacol; 1984 Dec 22; 26(6):699-705. PubMed ID: 6489409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative responsiveness of isolated saphenous, femoral and external carotid arteries and veins of dogs to dihydroergotamine mesylate (DEM) (author's transl)].
    Fukawa K, Honda H, Kubota H, Hatanaka Y, Sawabe T.
    Nihon Yakurigaku Zasshi; 1981 Sep 22; 78(3):223-30. PubMed ID: 7327451
    [Abstract] [Full Text] [Related]

  • 14. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Sep 22; 106(5-6):690-704. PubMed ID: 94863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Actions of co-dergocrine mesylate and its components at vascular smooth muscle.
    Müller-Schweinitzer E.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb 22; 318(3):225-33. PubMed ID: 7063048
    [Abstract] [Full Text] [Related]

  • 17. Effects of calcium channel blockers on the contractile response to dihydroergotamine in isolated human femoral veins.
    Glusa E, Markwardt F.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May 22; 335(5):529-33. PubMed ID: 3614388
    [Abstract] [Full Text] [Related]

  • 18. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration.
    Aellig WH, Rosenthaler J.
    Eur J Clin Pharmacol; 1986 May 22; 30(5):581-4. PubMed ID: 3758146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E.
    Gen Pharmacol; 1983 May 22; 14(1):95-102. PubMed ID: 6826043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.